These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21437437)

  • 1. Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil.
    Batista TP; Sabat BD; Melo PS; Miranda LE; Fonseca-Neto OC; Amorim AG; Lacerda CM
    Clinics (Sao Paulo); 2011; 66(1):57-64. PubMed ID: 21437437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the MELD allocation after its implementation in liver transplantation.
    Benckert C; Quante M; Thelen A; Bartels M; Laudi S; Berg T; Kaisers U; Jonas S
    Scand J Gastroenterol; 2011 Jul; 46(7-8):941-8. PubMed ID: 21443420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the survival of cirrhotic patients enlisted for liver transplantation in the pre- and post-MELD era in southern Brazil.
    Mattos ÂZ; Mattos AA; Sacco FK; Hoppe L; Oliveira DM
    Arq Gastroenterol; 2014; 51(1):46-52. PubMed ID: 24760064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved posttransplant mortality after share 35 for liver transplantation.
    Kwong AJ; Goel A; Mannalithara A; Kim WR
    Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.
    Salvalaggio P; Afonso RC; Pereira LA; Ferraz-Neto BH
    Einstein (Sao Paulo); 2012; 10(3):278-85. PubMed ID: 23386004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
    Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
    Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
    Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.
    Freitas AC; Itikawa WM; Kurogi AS; Stadnik LG; Parolin MB; Coelho JC
    Arq Gastroenterol; 2010; 47(3):233-7. PubMed ID: 21140081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of post-liver transplantation MELD and delta MELD in predicting early and late mortality.
    Zakareya T; Abbasy M; Abdel-Razek W; Elsiesy H; Abal Khail F; Al Sebayel M; Waked I
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1424-1427. PubMed ID: 28957872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Liver Transplant Recipients With Model for End-Stage Liver Disease Exception: Single-Center Experience in the Northeast of Brazil.
    Coelho GR; Praciano AM; Viana GNR; Lima CA; Feitosa Neto BA; Garcia JHP
    Transplant Proc; 2018 Jun; 50(5):1428-1430. PubMed ID: 29880366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELD as a metric for survival benefit of liver transplantation.
    Luo X; Leanza J; Massie AB; Garonzik-Wang JM; Haugen CE; Gentry SE; Ottmann SE; Segev DL
    Am J Transplant; 2018 May; 18(5):1231-1237. PubMed ID: 29316310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.